Clinical Study of Liposomal Paclitaxel in Chinese Patients
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose and dose limiting
toxicities of liposomal paclitaxel in Chinese patients with solid tumors in advanced stages.